BRGX Stock Price, Chart, Stats & News

BioRegenx, Inc.
Save
BioRegenx, Inc. (BRGX) does not currently pay a dividend.
5.83M
Market cap
–
Current P/E
–
Forward P/E
BRGX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Diagnostics & Research
Industry
BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally. The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products. It also develops TruScan.
Similar securities
Based on sector and market capitalization
Report issue





